CLNN - Clene Inc. Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
8.58 0.3 (3.5%)	---	---	---	---	0.3 (3.5%)	---	---

Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.

Category: PHARMACEUTICAL PREPARATIONS

Market Period: Closed

Earnings & Ratios

Basic EPS:: -0.78
Diluted EPS:
Basic P/E:: -11.3846
Diluted P/E:
RSI(14) 1m:: 72.41
VWAP:: 8.85
RVol:: 0.2404

Events

Period	Kind	Movement	Occurred At
1m	Price increase 1m	9.09 +0.22 (+2.54%)	Oct 15 10:09
1m	Price increase 1m	9.0 +0.12 (+1.35%)	Oct 15 09:48
1m	Price increase 1m	8.99 +0.23 (+2.63%)	Oct 15 09:43
1m	Price decrease 1m	8.84 -0.11 (-1.17%)	Oct 15 09:40
1m	Price increase 1m	8.86 +0.28 (+3.26%)	Oct 15 09:30